Contract & neutral-code manufacturing

Pharmaceutical Contract & Neutral-Code Manufacturing

KOIT facilitates own-label and neutral-code pharmaceutical manufacturing through qualified GMP-certified sites — matched to your molecule, dosage form, volume and target market.

Why partner with KOIT

Manufacturing arrangements built for international supply

Whether you need a straightforward own-label program or a discreet neutral-code structure, KOIT coordinates the right site and the documentation in between.

Own-label contract manufacturing

Have your pharmaceutical products manufactured at approved GMP-certified sites under your own brand, with full documentation support.

Neutral-code manufacturing

Discreet neutral-code programs for partners requiring branding flexibility without exposing the manufacturing site's identity.

Quality-assured sites

KOIT matches each program to sites meeting WHO-GMP, EU-GMP or PIC/S standards, appropriate for your target market's regulatory expectations.

Export-ready production

Manufacturing arrangements structured for international supply, with dossier, registration and export documentation coordinated end to end.

How it works

From requirement to released batch

KOIT manages the engagement as a structured program — from site matching and confidentiality arrangements through production, QA release and export logistics.

  1. 1

    Share your molecule, dosage form, volume and target-market requirements

  2. 2

    KOIT shortlists qualified manufacturing sites matched to the program

  3. 3

    Quality documentation and site information shared under confidentiality

  4. 4

    Commercial terms, batch sizes and lead times structured with the site

  5. 5

    Tech-pack, labelling and regulatory documentation coordinated

  6. 6

    Production, QA release and export logistics managed through KOIT

Pharmaceutical manufacturing and injectables production

The manufacturing network

Matched to the right site, not the nearest one

KOIT works with a curated network of qualified manufacturers and matches each program to the appropriate site — considering GMP standard, dosage-form capability, capacity, regulatory approvals and export experience. Site identities and audit details are shared confidentially with qualified counterparties.

Who it's for

Built for buyers with a product to bring to market

Importers and distributors launching own-label ranges

Marketing authorization holders needing a reliable manufacturing base

Pharmaceutical companies seeking neutral-code manufacturing

Institutional and government buyers requiring dedicated production

Brands requiring discreet manufacturing without site disclosure

Companies expanding into new markets needing registration-ready supply

FAQ

Common questions about contract and neutral-code manufacturing

Is KOIT itself a pharmaceutical manufacturer?+

No. KOIT is an international pharmaceutical business development company. We facilitate contract and neutral-code manufacturing through a curated network of qualified, GMP-certified manufacturing sites — we do not own or operate manufacturing facilities ourselves.

What is the difference between contract manufacturing and neutral-code manufacturing?+

In a standard contract manufacturing arrangement, your product is manufactured at a known site under your brand. Neutral-code manufacturing adds a layer of discretion — the product is manufactured at an approved site but the site's identity is not disclosed on the product or in outward-facing documentation, protecting sourcing strategy and channel relationships.

What quality standards do the manufacturing sites meet?+

Sites in KOIT's preferred network are assessed against WHO-GMP, EU-GMP or PIC/S standards, depending on the program and destination market. Site selection is matched to the regulatory requirements of your target country.

What dosage forms and therapeutic areas can be covered?+

Programs can span oral solids, injectables, liquids and other dosage forms across major therapy areas — including oncology, critical care, cardiovascular, CNS, respiratory, anti-infectives, nutraceuticals and dermatology — subject to site capability.

Who handles regulatory and registration documentation?+

KOIT coordinates the flow of dossier materials, GMP certificates, COPPs, FSCs and other registration documentation between the manufacturing site and your regulatory affairs team or local agent.

Can small or pilot batches be accommodated?+

Batch-size feasibility depends on the dosage form and the site. KOIT structures programs ranging from pilot and registration batches to commercial-scale volumes, and will advise on minimum order requirements during the enquiry stage.

How do I start a contract manufacturing enquiry?+

Send an enquiry through the Contact page or message us on WhatsApp at +91 84605 04665 with the molecule, dosage form, estimated volume and target market. Our team responds to qualified enquiries within one business day.

Ready to manufacture?

Discuss a manufacturing program with KOIT.

Tell us the molecule, dosage form, volume and target market. We'll match the program to the right qualified site and respond within one business day.